RTA Laboratuvarlari Biyolojik (RTALB) — Free Cash Flow Generation Index
RTA Laboratuvarlari Biyolojik (RTALB) has a Free Cash Flow Generation Index of 0.87x as of June 2025. Free cash flow of TL18.30 Million represents 1% of operating cash flow (TL20.98 Million). Read RTALB liabilities breakdown for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
RTA Laboratuvarlari Biyolojik Free Cash Flow Generation Index (2010–2023)
Historical FCF Generation Index trend for RTA Laboratuvarlari Biyolojik across 12 annual periods. Explore RTA Laboratuvarlari Biyolojik capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for RTA Laboratuvarlari Biyolojik (2010–2023)
Year-by-year Free Cash Flow Generation Index for RTA Laboratuvarlari Biyolojik. For the full company profile including market capitalisation, see RTALB market cap overview.
| Year | FCG Index | Free Cash Flow (TRY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.33x | TL23.93 Million | TL72.41 Million | TL48.48 Million | ▼ -51.6% |
| 2021 | 0.68x | TL46.98 Million | TL68.78 Million | TL21.43 Million | ▲ +186.2% |
| 2020 | -0.79x | TL-7.42 Million | TL9.37 Million | TL15.96 Million | ▼ -87.6% |
| 2019 | -0.42x | TL-1.51 Million | TL3.58 Million | TL5.19 Million | ▼ -155.3% |
| 2017 | 0.76x | TL1.07 Million | TL1.41 Million | TL318.64K | ▼ -58.7% |
| 2016 | 1.85x | TL5.28 Million | TL2.86 Million | TL2.42 Million | ▲ +45.4% |
| 2015 | 1.27x | TL7.86 Million | TL6.18 Million | TL1.67 Million | ▲ +1.8% |
| 2014 | 1.25x | TL3.22 Million | TL2.58 Million | TL640.00K | ▼ -32.5% |
| 2013 | 1.85x | TL20.82 Million | TL11.26 Million | TL9.56 Million | ▼ -4.5% |
| 2012 | 1.94x | TL4.33 Million | TL2.24 Million | TL2.09 Million | ▲ +60.2% |
| 2011 | 1.21x | TL1.95 Million | TL1.61 Million | TL335.00K | ▲ +1.1% |
| 2010 | 1.19x | TL3.32 Million | TL2.78 Million | TL541.00K | — |